deqularum + clindamycin

Deqularum + clindamycin is a combination drug consisting of deqularum and clindamycin. Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby preventing peptide chain initiation and elongation. It is primarily used to treat various bacterial infections, including acne vulgaris when applied topically[3][5][8]. Deqularum does not appear in major drug databases or literature as of May 2025, so its mechanism of action and clinical use are unclear; it may be a misspelling or an unrecognized/experimental compound. Combination therapies with clindamycin are commonly used for their synergistic antibacterial effects in dermatology (notably with benzoyl peroxide), but no established data exists for "deqularum + clindamycin" specifically.

Other names

deqularum + clindamycin